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1. INTRODUCTION 
Herbal medicine is the oldest form of healthcare known to mankind. They have been 
used by all cultures since time immemorial (Bhowmick et al., 2010). Medicinal Plants 
are of great importance in the case of an individual with respect to his health and to 
the community as well. The medicinal values of the plants are based on the presence 
of certain chemical substances, which produce a definite physiological action in the 
human body. 
Plants are Inevitable to man for his life. Plants have always been common source 
of medicament either in the form of traditional preparations or pure active 
principles.  All phyta of plants yield official and unofficial products of medicinal 
importance. The history of herbal medicine is as old as human civilization. India 
is virtually herbarium of the whole world. Even though the biological active 
compounds of some herbal drugs or their extracts are known, they are prescribed 
widely because of their effectiveness, minimum side effects in clinical experiences 
and relatively low costs. Alkaloids, tannins, flavonoids, and phenolic compounds are 
the most important bioactive phytoconsitutents (Okwu., 1999 and 2001). Medicinal 
Plant based drugs are advantageous because, they are simple, effective, and exhibit 
broad-spectrum activity. Thus we see that the importance of herbs in the management 
of human ailments cannot be overemphasized. It makes us clear that the plant 
kingdom has got a plentiful of active ingredients, which is very much valuable in the 
management of a huge number of diseases which are intractable. But these 
complimentary components give the plants as a whole a safety and efficiency much 
superior to that of its isolated and pure active components (Shariff., 2001). As per 
Ayurvedic, Indian medicinal plants are rich source of substances that have several 
therapeutic properties. About 75-85 % of the world's population, plant derived 
products still play an essential role in primary healthcare mainly in the developing 
countries (Dobhal et al.,2013).Indeed ,well into the twentieth century , much of the 
pharmacopoeia of scientific medicine was derived from the herbal care of the native 
people. 
According to the World Health Organisation, over 80% of the world‟s population or 
4.3 billion people rely upon such traditional plant based systems of medicine to 
provide them with primary health care (Attiso., 1983). 
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Medicinal plants are used to treat illness and diseases for thousands of years. They 
have gained economic importance because of their application in pharmaceutical, 
cosmetic, perfumery and food industries. The interest in herbal systems of medicine is 
growing day-by-day because nature can cure many diseases. Herbs are staging a 
comeback and herbal „renaissance‟ is happening all over the globe. The herbal 
products today symbolise safety in contrast to the synthetics that are regarded as 
unsafe to human and environment. Although herbs had been priced for their 
medicinal, flavouring and aromatic qualities for centuries, the synthetic products of 
the modern age surpassed their importance, for a while. However, the blind 
dependence on synthetics is over and people are returning to the naturals with hope of 
safety and security. 
 
Over three-quarters of the world population relies mainly on plants and plant extracts 
for health care. More than 30% of the entire plant species, at one time or other was 
used for medicinal purposes. It is estimated that world market for plant derived drugs 
may account for about Rs.2, 00,000 crores. Presently, Indian contribution is less than 
Rs.2000 crores. Indian export of raw drugs has steadily grown at 26% to Rs.165 
crores in 1994-‟95 from Rs.130 crores in 1991-‟92. The annual production of 
medicinal and aromatic plant‟s raw material is worth about Rs.200 crores. This is 
likely to touch US $5 trillion by the year 2050. 
It has been estimated that in developed countries such as United States, plant drugs 
constitute as much as 25% of the total drugs, while in fast developing countries such 
as China and India, the contribution is as much as 80%. Thus, the economic 
importance of medicinal plants is much more to countries such as India than to rest of 
the world. These countries provide two third of the plants used in modern system of 
medicine and the health care system of rural population depend on indigenous 
systems of medicine. 
Green plants synthesise and preserve a variety of biochemical products, many of 
which are extractable and used as chemical feed stocks or as raw material for various 
scientific investigations. Many secondary metabolites of plant are commercially 
important and find use in a number of pharmaceutical compounds. However, a 
sustained supply of the source material often becomes difficult due to the factors like 
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environmental changes, cultural practices, diverse geographical distribution, labour 
cost, and selection of the superior plant stock and over exploitation by pharmaceutical 
industry. Plants, especially used in Ayurveda can provide biologically active 
molecules and lead structures for the development of modified derivatives with 
enhanced activity and reduced toxicity. The small fraction of flowering plants that 
have so far been investigated have yielded about 120 therapeutic agents of known 
structure from about 90 species of plants (Joy et al.,). 
Some of the useful plant drugs include vinblastine, vincristine, taxol, 
podophyllotoxin, camptothecin, digitoxigenin, gitoxigenin, digoxigenin, tubocurarine, 
morphine, codeine, atropine, pilocarpine, capscicine, allicin, curcumin, artemesinin 
and ephedrine among others. In some cases, the crude extract of medicinal plants may 
be used as medicaments. On the other hand, the isolation and identification of the 
active principles and elucidation of the mechanism of action of a drug is of paramount 
importance. Hence, works in both mixture of traditional medicine and single active 
compounds are very important. Where the active molecule cannot be synthesised 
economically, the product must be obtained from the cultivation of plant material 
(Mukherjee & Mukhhetjee, 2005). 
Major pharmaceutical companies are currently conducting extensive research on plant 
materials gathered from the rain forests and other places for their potential medicinal 
value. Interest in herbal medicines has continued to grow. This is shown in several 
ways, for example, by increased retail sales of herbal medicinal products in Europe 
and the USA as well as the greater awareness among the public and healthcare 
professionals about natural health products and complementary therapies. Industrially 
produced new herbal products, mainly based on single-herb extracts standardized for 
its specific active ingredient, continue to be developed. 
In India knowledge of medicinal plant is very old, and medicinal properties of plants 
are described in 3500-1500 B.C, from which Ayurveda developed.  In Ayurveda the 
ancient well known treatise are Charak samhita dealing mostly with plants in sashrat 
samhita in which surgery is also maintained. In Egypt the people were familiar with 
medicinal properties of plants and animals. Greek scientists contributed much to the 
knowledge of natural history.  Hippocraties (460-370 B.C) is referred to as father of 
medicine and is remembered for his famous writings on kingdom, which is considered 
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authoritative even in the 20
th
 century. The substances from the plants were isolated, 
the structure was elucidated and the pharmacologically active constituents were 
studied. In 1934-1960 simultaneous applications of disciplines developed like organic 
chemistry, biochemistry, biosynthesis, pharmacology and modern methods and 
techniques of medicinal chemistry including paper, thin layer chromatography, gas 
chromatography and spectrophotometry. 
Plants have provided the lead molecules for a large number of diseases. During the 
past 40 years numerous novel compounds have been isolated from plant sources and 
many of these substances have been demonstrated to possess interesting biological 
activities. India is the treasure house of herbs and more than 9000 different herbs with 
varying medicinal properties are present. Ayurveda an ancient system of Indian 
medicine has recommended a number of drugs from indigenous plant and animal 
sources for the treatment of several diseases and disorders. More than 13,000 plants 
have been studied during the last 5 years (Trease and Evans;  Shah & Qadry 
1996; Varrote Tyler-iynn et al., 1996). 
1.1. Herbal Medicines  
Herbal Medicine sometimes referred to as Herbalism or Botanical Medicine, is the 
use of herbs for their therapeutic or medicinal value. An herb is a plant or plant part 
valued for its medicinal, aromatic or savory qualities. Herb plants contain a variety of 
chemical substances that has therapeutic value. 
Herbal Medicine is the oldest form of healthcare known to mankind. Herbs had been 
used by all cultures throughout history. It was an integral part of the development of 
modern civilization. Primitive man observed and appreciated the great diversity of 
plants available to him. The plants provided food, clothing, shelter and medicine. 
Much of the medicinal use of plants seems to have been developed through 
observations of wild animals and by trial and error. As time went on, each tribe added 
the medicinal power of herbs in their area to its knowledge base. They methodically 
collected information on herbs and developed well–defined herbal pharmacopoeias. 
Indeed, well into the 20
th
 century much of the pharmacopoeia of scientific medicine 
was derived from the herbal lore of native peoples. Many drugs commonly used today 
are of herbal origin. Indeed, about 25 % of the prescription drugs dispensed in the 
United States contain at least one active ingredient derived from plant material. Some 
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are made from plant extracts; others are synthesized to mimic a natural plant 
compound. 
Major pharmaceutical companies are currently conducting extensive research on plant 
materials gathered from the rain forests and other places for their potential medicinal 
value (WHO, 1993). 
1.2. Synthetic Drug: Dominance 
Pharmaceutical research took a major leap when alongside natural plants chemistry, 
pharmacologists, microbiologists and biochemists began to unravel the chemistry of 
natural products in human beings, animals, plants and microorganisms. Advances in 
synthetic organic chemistry led to the identification of many chemical molecules that 
offered more opportunities to develop novel compounds. Many new drugs emerged 
by this route, particularly those now being used to treat infections, infestations, 
cancers, ulcers, heart and blood pressure conditions. Many drugs were developed 
through random screening of thousands of chemicals synthesized as dye-stuffs and the 
like; many others resulted from serendipity arising from sharp eyed observations of 
physicians and scientists. Example of such drugs includes sulphonamides, isoniazid, 
antipsychotics, antihistamines and penicillin. Emergence of the modern 
pharmaceutical industry is an outcome of all these different activities that developed 
potent single molecules with highly active for a wide variety of ailments. The drugs 
produced in many cases improved on nature, a new range of local anesthetics from 
cocaine avoided its dangerous effects on blood pressure, and chloroquine is much less 
toxic than quinine. These successes and many more like them resulted in reduced 
interest in natural products drug discovery and many major drug companies almost 
neglected such divisions. Work on developing new drugs for the treatment of the 
world‟s major diseases such as malaria, trypanosomiasis, filariasis, tuberculosis, 
schistosomiasis, leshmaniasis and amoebiasis came almost to a standstill. In addition, 
although botanical medications continued to be produced in every country, the clinical 
efficacy of these was usually not evaluated and the composition of these complex 
mixtures was only crudely analyzed. Thus herbal medicines became the domain of 
„old wives tales‟ and quack medicine, exploitation of the sick, the desperate and the 
gullible. Sadly, herbal medicines continued to reflect poor quality control both for 
materials and clinical efficacy (Patwardhan
 
et al.,)
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1.3. Development of Phytomedicines for various diseases  
Medicinal plants play a key role in the human health care. About 80% of the world 
population relies on the use of traditional medicine, which is predominantly based on 
plant materials (WHO, 1993). The traditional medicine refers to a broad range of 
ancient natural health care practices including folk tribal practices as well as 
Ayurveda, Siddha, Amchi and Unani. These medical practices originated from time 
immemorial and developed gradually, to a large extent, by relying or based on 
practical experiences without significant references to modern scientific principles. 
These practices incorporated ancient beliefs and were passed on from one generation 
to another by oral tradition and guarded literature. Although herbal medicines are 
effective in the treatment of various ailments very often these drugs are 
unscientifically exploited and improperly used. Therefore, these plant drugs deserve 
detailed studies in the light of modern science. 
1.4. Phytotherapeutic Approach of Drug Development  
In phytotherapeutic approach, the emphasis is on the development of a new drug 
whose extraction and fractionation have emanated on the basis of therapeutic activity. 
The standard fraction of an active extract or mixture of fractions may prove better 
therapeutically, less toxic and inexpensive compared to pure isolated compound 
drugs. However, crude plant preparations require modern standards of safety and 
efficacy. Modern bioassay methods and physiochemical profile do provide ways and 
means of developing quality control as well as determining the expiry date of crude 
preparations or fractions. Standardized herbal preparations may serve as inexpensive 
and useful drugs to the masses. 
Herbal drugs have gained importance in recent years because of their efficacy and 
cost effectiveness. These drugs are invariably single plant extracts or fractions thereof 
or mixtures of fractions of extracts from different plants which have been carefully 
standardized for their safety and efficacy (Suck Dev
 
1997). 
1.5. Traditional Wisdom
 
 
Lag phase for botanical medicine is now rapidly changing for a number of reasons. 
Problems with drug resistant microorganisms, side effects of modern drugs, and 
emerging diseases where no medicines are available, have stimulated renewed interest 
in plants as a significant source of new medicines. Pharmaceutical scientists are 
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experiencing difficulty in identifying new lead structures, templates and scaffolds in 
the finite world of chemical diversity. A number of synthetic drugs have adverse and 
unacceptable side effects. There have been impressive successes with botanical 
medicines, most notably quinghaosu, artemisinin from Chinese medicine. 
Considerable research on Pharmacognosy, Chemistry, Pharmacology and Clinical 
therapeutics has been carried out on Ayurvedic medicinal plants. Numerous 
molecules have come out of Ayurvedic experimental base, examples include Rawolfia 
alkaloids for hypertension, psoriases in vitiligo, hypolipidemic agents, mucana 
pruriens for Parkinson‟s disease, piperidines as bioavailability enhancers, baccosides 
in mental retention, pierosides in hepatic protection, phyllanthins as antivirals, 
curcumine in inflammation and many other steroidal lactones and glycosides as 
immunomodulators. A whole range of chronic and difficult to treat diseases such as 
cancers, cardiovascular diseases, diabetes, rheumatism and AIDS all require new 
effective drugs. Most developing countries have relied and will continue to rely on 
traditional natural medicines due to the deterrence of high costs of modern allopathic 
medicines (Patwardhan
 
et al.,)
 
Current estimation indicates that about 80% of people in developing countries still 
rely on traditional medicine based largely on various species of plants and animals for 
their primary healthcare. Four out of ten Americans used alternative medicine 
therapies in 1997. Total visits to alternative medicine practitioners increased by 
almost 50 from 1990 and exceeded the visits to all US primary care physicians (Suck 
Dev
 
1997). 
1.6. Cancer  
Cancer is a general term applied to a series of malignant diseases which may affects 
many different parts of the body. These diseases are characterized by rapid and 
uncontrolled formation of abnormal cells which may mass together to form a growth 
or tumour, or proliferate throughout the body. Initiating abnormal growth at other 
sites, if the process is not arrested, it may progress until it causes the death of the 
organism. Cancer is commonly encountered in all higher animals, and plants also 
develop growth that resembles cancer. Next to heart disease, cancer is a major killer 
of mankind. Cancer is basically a disease of cells characterized by the loss of normal 
cellular growth, maturation and multiplication, and thus homeostasis is disturbed.  
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Carcinogens 
Carcinogens, the agents that cause cancer, have been classified into three broad 
groups' viz physical, chemical and biological. 
Physical agents 
Ultraviolet and ionizing radiations are mutagenic and carcinogenic, which may 
damage DNA in several ways. Ultraviolet radiation catalyzes the formation of 
covalent pyrimidine dimer, thus distorting the A-T, C-G bases pairing sequence in 
DNA strand. Ionizing radiation (X-rays, G-rays) can break the backbone of DNA 
molecule either by altering the base sequences structurally or by deletion of the bases 
from the backbone. Apart from direct effects on DNA, X-rays and G-rays cause free 
radicals to form in the tissues which can lead to oxidative DNA damage. 
 
Chemical agents  
It is estimated that 80% of human cancers are due to environmental factors, 
principally chemicals. A variety of compounds viz., polycyclic aromatic 
hydrocarbons, nitrosamines, alkylating agents and other inorganic and naturally 
occurring compounds are carcinogenic. Generally all carcinogens are electrophiles 
which attack nucleophilic groups in the DNA and RNA and proteins and thus damage 
the cell. 
Many of the alkylating agents can act directly on the target molecules (direct 
carcinogens) but there are other compounds, which cannot act directly and require 
prior metabolism to become carcinogens (procarcinogens). Thus chemical 
carcinogens can be classified as  
 Initiating agent   – which is capable of initiating cells only.  
 Promoting agent – capable of causing the expression of initiated cell clones. 
 Progressor agent – which can convert initiated cell or a cell in the stage of 
promotion to a potentially malignant cell.  
 A complete carcinogen has all the properties of initiating, promoting and 
progressor agents. 
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Another potential source of exogenous transforming mutations are certain 
biochemical processes which generate significant quantities of reactive oxygen 
species (ROS) and free radicals that are estimated to cause alterations in the DNA. 
Therefore, processes inherent in the cell and not necessarily dependent on exposure to 
exogenous agents may cause carcinogenesis. But it must be emphasized that 
environmental carcinogens significantly increase the risk of cancer and carcinogens 
do accelerate the process of carcinogenesis. The interaction of an “ultimate” 
carcinogen (i.e. the active electrophile) with DNA targets determines the formation 
and permanent fixation of transforming lesions. 
Biological agents 
The oncogenic viruses are well known and form a very diverse group of carcinogenic 
agents. They include members of all major families of DNA viruses that infect 
vertebrates except very small Parvovirus‟s and the very large Poxviruses. On the other 
hand, only one family of RNA viruses, the retroviruses, can cause tumors. The tumor 
viruses vary in complexity of their genomes, in the types of neoplasm they induce and 
in their requirement for co-factors in tumor genesis. RNA tumor viruses are 
characterized by the presence of RNA-dependant DNA polymerase (reverse 
transcriptase). Once the virus core enters the cell, the reverse transcriptase transcribes 
the single stranded RNA viral genome into double stranded DNA copies. The original 
viral RNA becomes degraded and the viral DNA copy (provirus) is then inserted 
(integrated) by a covalent linkage into the host cell DNA. 
Endogenous DNA damage from normal oxidation is enormous. The steady state of 
oxidative damage in DNA is about one million oxidative lesions per rat cell. This high 
background suggests that increasing the cell division rate must be a factor in 
converting lesions to mutations and thus cancer. Raising the level of either DNA 
lesions or cell division will increase the probability of cancer. Just as DNA repair 
protects against lesions, guards the cell cycle and protects against cell division if the 
lesion level gets too high. If the lesion level becomes still higher, can initiate 
programmed cell death (apoptosis).  
1.7. Main Features of Cancer 
 Excessive cell growth, usually in the form of tumor. 
 Invasiveness, i. e. the ability to grow into surrounding    tissue. 
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 Undifferentiated cells or tissue. 
 The ability to metastasize or spread to new sites and establish new growth; 
 A type of acquired heredity in which the progeny of cancer cells also retain 
cancerous property. 
 A shift of cellular metabolism towards increase in production of macromolecules 
from nucleosides and amino acids, with an increased catabolism of carbohydrates 
for cellular energy. Such behavior of cancer cells lead to illness in the host as a 
result of  
 Pressure effect due to local tumor growth; 
 Destruction of the organ involved by the primary growth; 
 Systemic effect as a result of new growth. 
 
1.8. Causes of Cancer 
Many factors are implicated in the causation of cancer. These factors are listed as  
 Exposure to the carcinogenic hydrocarbons or to excessive radiation. 
 Hereditary factors: A “cancer family syndrome” has been described by the 
Lynch et al., The hereditary factors involved in the causation of cancer are 
chromosomal abnormality, enzymes, immune defence system, hormonal 
imbalance etc. 
 Cultural factors: cultural factor play a dominant role by causing about 70 % of 
all cancers. The important amongst are diet, smoking, drinking and sexual 
habits. 
 Occupational factors: These factors are ionizing radiation, chemicals and other 
substances for example- coal tar, mustard gas, chromium, hematite, nickel and 
asbestos can trigger lung cancer in employees working in chemical, insulation 
and gas factories. 
 Viruses: Though it is known that viruses cause cancer in animals, their role in 
human cancer has not been proved. 
1.9. Cell Cycle   
Cellular multiplication involves passage of cell through a cell cycle. The 
various phases of cell cycle are characterized as: 
 The interval following cell division to the point where DNA synthesis starts, 
known as the presynthetic phase G1. 
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 After mitosis some of the daughter cells pass into a resting phase or non 
proliferative phase G0 and do not re-enter the cell cycle phase G1 immediately. 
They may enter the G1 phase later. 
 DNA synthesis phase (S). 
 The premitotic or postsynthetic (G2) phase fallows. In this phase RNA and 
protein synthesis takes place. 
 Mitotic phase (M) follows. 
1.10. Criteria for Antineoplastic Drug (Anticancer drug) 
The term „anticancer drug‟ is emotive and can build up false hopes among cancer 
sufferers. Investigator in the United States National Cancer Institute (NCI) program 
have used the term cytotoxic, antitumour and anticancer to describe the activity of the 
compound isolated according to the following definitions.  A cytotoxic agent is toxic 
to tumour cell in- vitro and if this toxicity transfers through the tumour cell in vivo, 
the agent is said to have antitumour activity.  The term anticancer is reserved for 
material, which are toxic to tumour cell in clinical trials.  
1.11. An antineoplastic drug should be: 
(1) Cytotoxic: To inhibit the cancer cell metabolism, particularly synthesis of 
protein and nucleic acid, in order to prevent cell growth, differentiation, 
vascularization of the new growth etc. 
(2) Mitostatic: To disrupt the process of cell division, to prevent the uncontrolled 
number of cycles of cell division and growth, to retard the proliferation of the 
cancerous tissue. 
(3) Nontoxic: The drug should be nontoxic to the rest of the body of the patient; it 
should not cause any side effect such as renal or hepatic dysfunction, 
neurotoxicity, hypersensitivity etc. 
(4) Target oriented:  It should be site-selective targeting in action to the 
cancerous region and not cause the same effect (or at least not cause them to 
the same degree as on cancer) on the other part of patient‟s body. 
The drug should be effective in small and few doses, should not be expensive, should 
have longer half-life, freely available on the market, etc., These criteria for an 
anticancer drug are a tall order. Hardly there is any drug, synthetic or natural, that 
meets with all these qualification and so the choice is dictated by the maximum 
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compliance of the criteria and the philosophy of the „Lesser evil’. With the presence 
of a large number of different types of cancer, each a kind of a syndrome, no single 
drug can be expected to be effective against more that are, at the best a few of related 
cancers (Barar
 
2003; Singh & Lippman 1998). 
1.12. Plants in the Treatment of Cancer  
In the face of failure to find synthetic drugs against cancer, thousands species of 
plants have been screened since a long time, for antineoplastic activity, in the hope of 
discovering effective natural products. Compounds have been isolated from hundreds 
of species and their activities in suppressing tumours induced in laboratory animals 
have been evaluated. Such work is still going on in several laboratories throughout the 
world. The Natural Product Drug Development Program of the U.S. National Cancer 
Institute has identified about 3,000 species of plants and animals as useful in dealing 
with one or the other aspect of cancer management. Basing on in vitro data, a large 
number of species have been identified to be of promise and taken to clinical trials. 
However, products of hardly a handful of plant species, such as the Vinca alkaloids, 
taxol, camptothecin, podophyllotoxin, etc., have passed through the rigorous tests to 
be officially used against certain types of cancer and are now available in the market. 
1.13. Plants in the management of cancer 
In addition to the handling of the cancer proper, a host of synthetic or plant based 
drugs are used in the biomedical system in the management of cancer, which is 
distinct from treatment aimed at a cure. The better hope of usefulness of plants lies in 
the areas of detection, prevention, management of symptoms inherent in the disease or 
incidental to the treatment, post-cure management such as the recovery of the body to 
full and normal functioning, prevention of remission, and management of symptoms 
of incurable cancers, to keep the patients in the maximum possible comfort.  
1.14. Plants in the prevention of cancer 
There is a prevailing hope that „someday people should be able to avoid cancer or 
delay its onset by taking specially formulated pills or foods. Chemoprevention is the 
attempt to use natural and synthetic compounds to intervene in the early pre-
cancerous stages of carcinogenesis, before the invasive disease begins, as prevention 
of cancer is immensely better than its uncertain cure. 
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Food has been identified as one of the most promising sources of chemopreventive 
agents. These include vitamins A (and its analogues), C and E, which are obtained by 
us only from plants. Some plant products without any recognised nutritional value 
such as indoles, isothiocyanates, dithiolthiones and organosulphur compounds have 
been shown to be chemopreventive. Dithiolthiones and organosulphur compounds are 
abundant in broccoli, cauliflower and cabbage. Genistein from soyabean, and 
epigallocatechin, the bulk of solid material in brewed tea have also been found to be 
chemopreventive, as well as turmeric, ginger and saffron. 
Among the plant-based chemopreventives, β-carotenes, the precursors of vitamin A, 
are rated high. In addition to carrots, they are present in a large number of plants, 
particularly abundant in the leafy vegetables. These food plants also provide the 
dietary fibre that is believed to prevent colon cancer. It is not yet very clear how the 
chemopreventive agents function. Some are believed to prevent the mutations that can 
lead to cancer, some halt the process of excessive proliferation of altered cells, and 
some hasten apoptosis (death of cells) of altered cells, while some function as 
antioxidants and scavenge the free radicals that may trigger cancer (VandeCreek et 
al., 1999). 
1.15. Cancer Chemotherapy  
The chemotherapy of neoplastic disease has become increasingly important in recent 
years. An indication of this importance is establishment of a medical specialty in 
oncology in which the physician practices various protocol of adjuvant therapy. Most 
cancer patient now receives some form of chemotherapy, even though it is merely 
palliative in many cases. The relatively high toxicity of most anticancer drugs has 
fostered the development of supplementary drugs that may alleviate these toxic 
effects or stimulate the regrowth of depleted normal cells. There is a cogent reason 
why cancer is more difficult to cure than bacterial infections. One is that there are 
qualitative differences between human and bacterial cells. For example bacterial cell 
have distinctive cell walls, and their ribosome differ from those of human cells. In 
contrast, the differences between normal and neoplastic human cells are mostly 
quantitative. Another difference is that immune mechanism and other host defences 
are very important in killing bacteria and other foreign cells, whereas they play a 
lesser role in killing cancer cells. 
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1.16. INDIAN SCENARIO 
The global context sketched above suggest several tremendous opportunities for 
India, a country with unrivalled terms of diversity of medicinal systems and practices, 
in addition to being a major storehouse of biological diversity, with 2 of the 4 mega 
diversity areas of the world located within its borders. In addition several concerns 
arise in relation to the current consequences of participation in the market, with regard 
to the sustainable and equitability of prevailing practices in the sector.  
To add to all these aspects, the market in India has been shown to be highly inefficient 
and imperfect. The need of the hour then is to replant India's participation in the 
expanding global market. Such an overview could form the basis of a renewed 
development of India's medicinal plant sector, and a strategic exploitation of other 
comparative advantage in the global market on a sustainable and equitable basis. 
1.17. Drug designing for cancer
 
In designing specific regimens for clinical use, a number of factors must be taken into 
account. Drugs are generally more effective in combination and may be synergistic 
through biochemical interactions. These interactions are useful designing new 
regimens.  It is more effective to use drugs that do not share common mechanisms of 
resistance and that do not overlap in their major toxicities. Drugs should be used as 
close as possible to their maximum individual dose and finally, drugs should be used 
as close as possible to discourage tumor growth and maximize dose intensity (the 
dose gives per unit time, a key parameter in the success of chemotherapy).  Based on 
experimental tumor models, it is necessary to eradicate all tumor cells. The fraction of 
cells killed with each treatment cycle is constant, with regrowth between cycles. Thus, 
it is desirable to achieve maximal cell kill with each cycle, using the highest drug dose 
possible, and to repeat dose as frequently as tolerated.  Since the tumor cell population 
in patients with visible disease exceeds 1gm, or 10
9
 cells, and since each cycle of 
therapy kills less than 99% of the cells, it is necessary to repeat treatments in multiple 
cycles to kill all the tumor cells. 
The activity of many of the drugs currently used in cancer chemotherapy can probably 
be ascribed to inhibition of nucleic acid synthesis, but mechanism of action differs 
widely. Some compounds are mitotic inhibitors for example colchicine, 
podophyllotoxin, vincrystine and maytansine, and they act by binding to the protein 
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tubulin in the mitotic spindle, preventing polymerization and assemble into 
microtubules, and after cell division, the microtubules are transformed back to 
tubulin. 
Although podophyllotoxin is a tubulin binder, it is intriguing that the semisynthetic 
anticancer drugs etoposide and teniposide derived from it have a different mode of 
action. These drugs inhibit DNA synthesis and replication via the enzyme 
topoisomerase II. Camptothecin derivatives, topotecan and irinotecan, exert their 
cytotoxic action through inhibition of topoisomerase I system. Topoisomerase are 
fundamental enzyme complex involved in DNA replication by their ability to break 
and reseal the DNA strands. 
With the identification of an increasing number of molecular targets associated with 
particular cancers, high throughput screening of compounds against a range of such 
targets now forms the basis of anticancer drug discovery. Examples are the cyclin 
dependant kinases, which, together with their cyclin parameters, play a key role in the 
regulation of cell cycle progression, and inhibition of their activity delays or arrest 
progression at specific stages of cell cycle. These are over 2000 kinases so for 
identified for genomic studies and all have a common site, the position where the 
ATP, that is, the source of phosphate that is donated, is bound. The moderately 
antitumor flavonoids, quercetin, is an early example of natural product compound 
class that ultimately led to CDK inhibitors. This flavonoids resembles an ATP mimic 
where the planar bicyclic chromone ring system is an isostere of adenine. Quercetin 
exerts its antitumor effect through blocking cell cycle progression at the G0/G1 
interface, consistent with Cyclin dependant kinase inhibition.  
Taxol is a naturally occurring highly derivatised diterpene belonging to taxane group 
of compounds present in genus Taxus under family Taxaceae.  A derivative of taxol-
taxofere has been reported to have better bioavailability and pharmacological 
properties.  The bio target of taxol is microtubule responsible for formation of mitotic 
spindle necessary for cell division which causes detrimental effects leading to 
blockage of cell cycle (Wilson and Gisvold
 
2004). 
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2. Plant Profile 
(Wealth of India, 2003 [Anon]; Devasagayam 2007; Wealth of India, CSIR, 1969; 
Indian Medicinl Plants [Kitikar & Basu] 1975, 1987, 1999; The Flora of Orissa; 
Saxsena & Brahmam, 1994; Sharma et al., 2005; Sharma 2003; Swain & Das 2007; 
Nadkarni 1976; Kapoor, 1989). 
Botanical Name: Pterocarpus marsupium Roxb.  
Botanical Source: The plant consists of the bark, leaves, heartwood of Pterocarpus 
marsupium P. marsupium 
Order: Fabales 
Family: Leguminosaa (Fabaceae) 
Subfamily: Faboideae 
Tribe: Dalbergieae 
Genus: Pterocarpus 
Species: marsupium 
Authority: Roxb. 
 
Vernacular names: (Sharma 2003; Swain & Das 2007) 
1. Sanskrit: Pitasala, Bijaka, Murga 
2. Hindi: Bijasal 
3. English: Malabarkino; Indian Kino Tree 
4. Bengali: Pitsal 
5. Nepalese: Bijasar 
6. Sinhalese: Gammalu 
7. German: Malabarkino 
8. Kannada: Honne 
8. French: Pterocarp 
9. Unani: Dammul-akhajan 
10. Arabian: Dammul Akhwayn 
11. Persian: Khoon-e-siyaun-shan 
12. Tamil: Vengai  
13. Telugu: Yegi 
14. Malayalam: Venga 
 
P. marsupium, also known as Malabar kino, (Gamble, 1935) Indian kino tree or 
vijayasar, is a medium to large, deciduous tree that can grow up to 30 metres tall. It is 
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native to India, Nepal, and Sri Lanka, where it occurs in parts of the Western Ghats in 
the Karnataka-Kerala region and also in the forests of Central India. Parts of the 
Indian kino (heartwood, leaves, and flowers) have long been believed to have 
medicinal properties in Ayurveda (The Flora of Orissa, Saxsena & Brahmam, 1994). 
In Karnataka the plant is known as honne or kempu honne. The Kannada people in 
India make a wooden tumbler from the heartwood of this herb tree (Saldanha, Flora 
of Karnataka, 1984). 
Bark of Pterocarpus marsupium    Leaves of Pterocarpus 
marsupium 
 
 
 
2.1 Habitat 
A moderate to large deciduous tree about 90ft or more high, commonly found in hilly 
region of central and peninsular India (Andhra Pradesh, Bihar, Gujarat, Kerala, 
Madhya Pradesh, Maharashtra, Karnataka, Orissa, Tamilnadu, Uttar Pradesh); found 
at 3000 ft in Gujarat, Madhya Pradesh and Himalayan & sub Himalayan tracts-Nepal 
(Kapoor, 1989) and Sri Lanka. It grows on a variety of formation provided the 
drainage is good. It prefers a soil with a fair proportion of sand though it is often 
found on red loam with a certain amount of clay. The normal rainfall in its natural 
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habitat ranges from 75 to 200cm but it attains its largest size in parts of Mysore and 
Kerala, where the rainfall is even higher. It is a moderate light demander and the 
young seedlings are frost-tender (Wealth of India, CSIR, 1969). 
Parts used: Bark, Leaves, Kino (gum) 
 
2.2 Pharmacognostical Characteristics 
Morphology 
It is a moderate-sized to large deciduous tree. bark grey, longitudinally fissured and 
scaly. The older trees exude a blood red gum-resin. 
Description 
Leaves: compound; with 5 to 7 leaflets, 3 to 5 in long, oblong or elliptical with  wavy 
margin or rounded or obtuse or retuse ends, glaucous beneath, secondary nerves close 
and parallel, over 12 cm each side.  
Flowers: yellow, , up to 1.5 cm long, corolla papilionaceous, exserted beyond calyx, 
Stamen 10, split in 2 bundles , yellow, in very large, dense bunches.  
Fruits: 2 to 5 cm long, roundish, winged, with one seed. Legume indehiscent, 
orbicular, compressed, broadly hardened winged around margin, usually single 
seeded, seeds subreniform, hilum small.  
The Heartwood: is golden to yellowish brown with dark streaks staining yellow 
when damp and turning darker on exposure, strong and tough. 
 
2.3 Microscopic Characteristics 
The wood consists of vessels, tracheids, fibre tracheids and wood parenchyma all the 
elements being lignified and filled with tannin. Vessels are medium sized drum 
shaped, scattered, leading to semiring-porous conditions, tyloses present. Tracheids 
are long, abundant, thick walled, with tapering ends and simple pits on the side walls. 
Xylem parenchyma is small, thick walled with blunt ends; rectangular simple pitted 
surrounding the vessel. A few crystal fibers are observed in tangential section of the 
wood. Tree bark yields a reddish gum known as Kino gum, which becomes brittle on 
hardening and is very astringent. Sclerenchyma diffused pores Red marks are resin 
canals 8 Stem hairs overlapping metaxylem and protoxylem. 
 
2.4 Chemical Constituents 
Researches in the past have established the genus Pterocarpus to be the rich sources 
of polyphenolic compounds. All active principles of P. marsupium are thermostable. 
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The primary chemical components of P. marsupium are pterosupin, pterostilbene, 
isoliquiritigenin, liquiritigenin, epicatechin, kinotannic acid, kinoin, kino-red beta-
eudesmol, 
marsupol, carpusin and marsupinol. 
The plant contains pterostilbene 4-5%, alkaloids 0.4%, tannins 5%, protein, pentosan, 
pterosupin, pseudobaptigenin, liquiritigenin, isoliquiritigenin, garbanzol, 
5-de-oxykaempferol, P-hydroxybenzaldehyde, beudesmol, 
erythrodirol-3-monoacetate, l-epicatechin, marsupol, carpusin, propterol, propterol B, 
marsupinol, irisolidone-7- O-A-L-rhamnopyranoside, have been obtained mainly 
from the heartwood and root.  
The gum kino from the bark provides non-glucosidal tannins - kinotannic acid, 
kinonin (C28H24O12), kino-red (C28H22O11), pyrocatechin, pyrocatechin acid & 
small quantities of resin, pectin and gallic acid. 
Aqueous extract of the heartwood of Pterocarpus marsupium contains 5 new 
flavonoids C-glucosides namely 6-hydroxyl-2-(4-hydroxybenzyl)-benzo- 
furan-7-C-â-D-glucopyr anoside, 3-(á -methoxy-4-hydro xybenzylidene) 
-6-hydroxybenzo-2(3H)-furanone-7-C-â- D-glucopyranoside, 2-glucopyranoside, 
8-(C-â-D-glucopyranosyl)- 7,3,4-trihydroxyflavone and 1,2-bis (2,4-dihydroxy, 
3-C-glucopyranosyl) – ethanedione and two known compounds C-â-D- 
glucopyranosyl-2,6-dihydroxyl benzene and sesquiterpene were isolated Ether extract 
of the roots of   Pterocarpus marsupium consists of a new flavonol glycoside 6- 
hydroxy-3,5,7,4-te tramethoxyflavone 6-O-rhamnopyranoside, 8­hydroxy­4‟­m 
ethoxyisoflavone-7-O-glucopyranoside.  
A benzofuranone derivative 2,4‟6­trihydroxy­4­methoxy benzofuran­3(2H)-one   
designated carpus in, 1,3-bis(4-hydroxyphenyl) propan-2-ol designated propterol, 
1-(2,4-di hydroxyphenyl )-3-(4-hydroxyphenyl ) propan-2-ol designated propterol, 
6-hydroxy-7-O- methyl-3-(3-hydroxy-4-O-methyl benzyl) chroman-4-one. Ethyl 
acetate extract of root contains benzofuranone, marsupin, dihydrochalcone, 
pterosupin, stilbene, pterostilbene, aliquiritigenin, isoliquiritigenin.  
Methanolic extract of heart wood c ontains an isoflavone  7-O-á-L-rhamno- 
pyranosyloxy­4‟­methoxy­5­hydroxy­isoflavone. Three new isoflavone glycosides 
viz retusin 7-glucoside, irisolidone 7-rhamnoside and 5,7-dihydroxy-6-methoxy 
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isoflavone 7-rhamnoside have been isolated from the heartwood of Pterocarpus 
marsupium. 2,6-
dihydroxy-2-(P-hydroxybenzyl)-3(2H)-benzofuran-7-C-â-D-glucopyranoside 
(Maurya et al., 2004; Gairola et a., 2010; Yogesh et al., 2010; Tiwari & Khare 2015). 
2.5 Ethnomedicinal Uses (Tiwari et al., 2015) 
Useful parts of the herb are heartwood, leaves, flowers, gum. The genus is widely 
distributed on the Earth and the astringent drug from this genus is known as “Kino”. 
The phloem of stem contains red astringent fluid present in secretory cell, which 
exudes after given incision. Kino is odourless but has astringent taste and sticks in the 
teeth, colouring the saliva red in colour. As astringent it is used in diarrhoea, 
dysentery etc. 
Bruised leaves are applied on fractures, leprosy, leucoderma, skin diseases, sores and 
boils, Constipation, depurative, rectalgia, opthamology, hemorrhages and Rheumatoid 
arthritis. Marsupin and Pterostilbene significantly lower the blood glucose levels 
useful in NIDDM. Bark is used as diuretic in Gabon and fresh leaves are used as food 
in Nizeria. Also is used in the form of powder or decoction in diarrhoea, and 
decoction is very useful for diabetic patients. 
Stem in the treatment of neurological problems. 
Leaves are used in GIT disorders, wood, stem bark, seed and flours are used in 
African traditional medicine, especially in the Cameroonian pharmacopoeia, for 
treating various diseases including hypertension, diabetes, intestinal parasitizes, renal 
and cutaneous diseases. The leaf paste is used as an ointment to treat skin diseases, 
sores and boils. 
Wood: The heartwood is used as an ointment to astringent, bitter, acrid, cooling, anti-
inflammatory, union promoter, depurative, urinary astringent, haemostatic, 
asthelmintic, constipating, anodyne alterant and rejuvenation. It is also useful in 
elephantiasis, inflammations, fractures bruises, leprosy, skin disease, leucoderma, 
erysipelas urethrorrhoea, diabetes, rectalgia, rectitis, opthalmopathy, diarrhea, 
dysentery, cough, asthma, bronchitis and greyness of hair.  
Flower: The flower is used as appetizing and febrifuge and also taken to treat 
anorexia and fever.  
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Gum-resin: The gum is taken to treat bitter, styptic, vulnerary, antipyretic, 
anthelmintic and liver tonic. It is useful in spasmodic gastralgia, boils, gleet, 
urethrorrhoea, odontalgia, diarrhea, psoriasis, wound and ulcers, helminthasis, fevers, 
hepatopathy and ophthalmia. 
Some facts: P. marsupium is a plant drug belonging to a group called „Rasayana‟ in 
Ayurvedic system of medicine. These „Rasayana‟ drugs are immunomodulators and 
relieve stress in the body. In India, Kannada peoples are used to make a wooden 
tumbler from the heartwood. Water is left overnight in the wooden tumbler and is 
consumed in the next morning to cure diabetes. Kol tribes in Odisha pound a paste 
mixture of the bark of P. marsupium with the bark of Mangifera indica, Shorea 
robusta & Spondias pinnata to treat some dysentery illness. The gum resin of this 
plant is the only herbal product ever found that regenerate beta cells that produce 
insulin in pancreas. 
2.6 Biological activity 
Although a large number of compounds have been isolated from various parts of P. 
marsupium, few of them have been studied for biological activity as shown in Table 
1. The structure of some of these bioactive compounds has been presented in Figure 
1. The bark contains l-epicatechin and a reddish brown colouring matter. The bark is 
occasionally employed for dyeing. The heartwood yields liquiritigenin, 
isoliquirtigenin, a neutral unidentified component, alkaloid and resin. The wood also 
contains a yellow colouring matter and an essential oil and a semi-drying fixed oil. 
The tree yields a gum-Kino which exudes when an incision is made through the bark 
up to the cambium. It is odourless and bitter with astringent taste and colours saliva 
pink when masticated. Kino contains a non-glucosidal tannin kinotannic acid, kinoin 
and Kino-red, small quantities of catechol, protocatechuic acid, resin, pectin and 
gallic acid. The therapeutic value of Kino is due to Kino is due to kinotannic acid. 
Kino is powerfully astringent and was formerly used widely in the treatment of 
diarrhea and dysentery. It is locally applied in leucorrhoea and in passive 
haemorrhages. It is also used for toothache. The bark is used as an astringent and in 
toothache. The flowers are said to be used in fever. The bruised leaves are considered 
useful as an external application for boils, sores and skin diseases. The aqueous 
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infusion of the wood is said to be of use in diabetes and water stored in vessels made 
of the wood is reputed to have antidiabetic qualities (Anon, Wealth of India, 2003). 
2.7 Medicinal use of various parts of P.marsupium 
Various parts of the P. marsupium tree have been used as traditional ayurvedic 
medicine in India from time immemorial. The medicinal utilities have been described, 
especially for leaf, fruit and bark. The bark is used for the treatment of stomachache, 
cholera, dysentery, urinary 
complaints, tongue diseases and toothache. The gum exude „kino‟, derived from this 
tree, is used as an astringent (Singh et al., 1965). The gum is bitter with a bad taste. 
However, it is antipyretic, anthelmintic and tonic to liver, useful in all diseases of 
body and styptic vulnerant and good for griping and biliousness, opthalmiya, boils 
and urinary discharges. The flowers are bitter, improve the appetite and cause 
flatulence (Indian Medicinal Plants 1999). P. marsupium has a long history of use in 
India as a treatment for diabetes. It is a drug that is believed to have some unique 
features such as beta cell protective and regenerative properties apart from blood 
glucose reduction (WHO 1980; Chakravarthy et al., 1981). Some of the medicinal 
attributes of various parts of P. marsupium have been summarized (Yogesh et al., 
2010) in table 2. 
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3. Literature Review 
 
3.1. Anti-diabetic and antioxidant activity 
P. marsupium demonstrates unique pharmacological properties, which include beta 
cell protective and regenerative properties as well as blood glucose lowering activity. 
The animal studies conducted have used various species including rats, dogs, and 
rabbits with induced diabetes and subsequent treatment with various extracts of P. 
marsupium. In all of these studies, P. marsupium was found to reverse the damage to 
the beta cells and actually repopulate the islets, causing a nearly complete restoration 
of normal insulin secretion (Chakravarthy et al., 1982; Manickam et al., 1997; Ahmad 
et al., 1991; Pandey & Sharma 1976; Shah 1967; Chakravarthy et al., 1982). 
 
In one study it was shown that aqueous extract of P. marsupium modulates the 
inflammatory cytokine TNF-alpha in type 2diabetic rats and this has an indirect effect 
on PPAR-Gamma expression. By decreasing TNF-α, drug can upregulate the PPAR-
Gamma and in turn the glucose metabolism (Halagappa et al., 2010). 
 
The bark of P. marsupium is traditionally used in the Indian Ayurvedic system of 
medicine as an anti-diabetic drug. The compound that is responsible for antidiabetic 
activity is (-) epicatechin, a member of the catechin group of compounds belonging to 
the class of flavonoids (Zaid et al., 2002). 
 
It has been shown that P. marsupium works by the regeneration of the beta cells and 
increase proinsulin biosynthesis. Marsupin and Pterostilbene significantly lowered the 
blood glucose level of hyperglycemic rats, and the effect was comparable to that of 
1,1-dimethyl biguanide (metformin)  (Manickam et al., 1997). 
 
Overnight water stored in water tumblers made out of the heartwood of P. marsupium 
is used as a traditional therapy for patients of Diabetes mellitus especially in the state 
of Madhya Pradesh (Maheswari et al., 1980).  
 
Isolated compounds from P. marsupium have been shown to enhance the conversion 
of Pro-insulin to insulin and stimulate cAMP content in the islets of Langerhans 
(Ahmad et al., 1991). 
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It is proposed that the flavonoid fraction of P. marsupium bark effectively reverses the 
alloxan induced changes in the blood sugar level and the beta cell population in the 
pancreas (Chakravarthy et al., 1980). 
 
P. marsupium methanol extract has been found to cause normalization of serum 
protein and albumin levels, possibly through the increase in insulin mediated amino 
acid uptake, enhancement of protein synthesis and inhibition of protein degradation 
(Dice et al., 1978). 
 
Administration of the bark extract to diabetic rats restored the levels of serum 
electrolytes, glycolytic enzymes and hepatic cytochrome p-450 dependent enzyme 
systems by inhibiting the formation of liver and kidney lipid peroxides (Gayathri and 
Kannabiran et al., 2010). 
 
3.2. Cardiotonic activity 
Cardiotonic activity was reported of the aqueous extract of heartwood of P. 
marsupium. This plant species contains 5,7,2-4 tetrahydroxy isoflavone 6-6 glucoside 
which are potent antioxidants and are believed to prevent cardiovascular diseases. The 
cardiotonic effect of the aqueous extract of heartwood of P. marsupium was studied 
by using the isolated frog heart perfusion technique. Calcium free Ringer solution was 
used as vehicle for administration of aqueous extract of P.marsupium as a test extract 
and digoxin as a standard (Mohire  et al., 2007). Liquiritigenin and Pterosupin, the 
flavonoid constituents of P. marsupium are effective against reducing serum 
cholesterol levels, LDL cholesterol, and atherogenic index. Pterosupin being 
additionally effective in lowering serum triglycerides (Jahromi and Ray.,1993). 
 
3.3. Hepatoprotective activity 
Methanol extract of the stem barks of P. marsupium possesses significant 
hepatoprotective activity (Mankani et al., 2005). 
 
3.4. Antioxidant activity 
The whole aqueous extract of the stem bark of P. marsupium showed high anti-
oxidant activity and protects the mitochondria against oxidative damage (Mohammadi 
et al., 2009). 
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Heartwood extracts of P. marsupium promotes wound healing in both normal and 
diabetic animals by topical application of the extracts (Singhal et al., 2013). 
Ethanol extracts of the heartwood of P. marsupium is found to be useful in preventing 
allergic conditions and diseases such as asthma owing to its ability to decrease the 
increased eosinophilic , leucocytic count, prevention of mast cell degranulation 
(Suralkar et al., 2012). 
 
Antidiarrhoeal activity of Ethanol heartwood extract of Pterocarpus marsupium was 
also studied (Dilpesh et al., 2011). 
3.5. Antibacterial activity 
Hexane, ethyl acetate and methanol extracts were tested against four selected Gram 
positive and Gram negative bacteria- S. aureu, K. pneuminiae, and P. aeruginosa 
(Sapha 1956; Gayathri and Kannibaran ., 2010). In vitro, it inhibits Pseudomonas 
aeruginosa, Streptococcus pyrogens and Staphylococcus aureus. Ethyl and methanol 
extracts were more sensitive to the bacteria than extracts made out of hexane. Both 
the extracts exhibited concentration dependent variation in their anti-bacterial activity. 
Similar observations have been reported where it has been showed that ethanol 
extracts of P. marsupium exhibited significant anti-ulcer and antioxidant properties in 
rats (Nair et al., 2005; Patil & Gaikwad, 2011). 
 
3.6. Anti-inflammatory activity 
P. marsupium has also shown strong potential for its antiinflammatory activity. In this 
study, an extract of P. marsupium containing pterostilbene has been evaluated for its 
PGE2- inhibitory activity in LPS-stimulated PBMC. In addition, the COX-1/2 
selective inhibitory activity of P. marsupium extract was investigated (Hougee et al., 
2005; Salunkhe et al., 2005). 
 
3.7. Central Nervous System 
The methanol extracts of P. marsupium has potent nootropic activity (Chauhan and 
Chaudhary, 2012). 
 
3.8. Other Studies 
Anti-cataract activity of P. marsupium in diabetes was observed (Vats et al., 2004). 
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Lukewarm aqueous suspension of 2g gum with jaggery is given early in the morning 
for a week to treat asthma (Patil et al., 2008). 
Bark is useful in vitiated condition of kapha, pitta, elephantiasis, erysipelas, 
urethrorrhea, rectalgia, opthalmopathy, hemorrhages, dysentry, cough, and grayness 
of hair (Patil and Gaikwad., 2011). 
 
20g of the stem bark boiled with 1 litre of water till 200ml along with 7 black pepper 
dried seeds of Piper nigrum) taken orally cures spermaturia, spermatorrhea, 
leucorrhoea, amenorrhoea, dysmennorhoea, menorrhagia and impotency (Behera and 
Mishra ., 2005). 
 
Table 1. Primary chemical components from Pterocarpus marsupium 
Neem compound Source Biological Reference 
Liquiritigenin bark   Antidiabetic, 
Antihyperlipidemic effect 
Jahromi & Ray 1993 
Isoliquiritigenin bark  Antidiabetic Jahromi & Ray 1993 
Pterosupin Antihyperlipidemic effect Jahromi & Ray 1993 
Epicatechin bark Antidiabetic, Anthelmentic 
properties  
 
Pterostilbene bark blood glucose levels, Anti-
oxidant and anti tumor 
effects 
Grover et al., 2005 
Marsupinol bark Antihyperlipidemic effect Jahromi & Ray 1993 
   
 
Table 2. Some medicinal uses of Pterocarpus marsupium as mentioned in 
Ayurveda 
Parts Medicinal use 
Leaf External application for boils, sores and 
skin diseases, stomach pain 
Bark Astringent, toothache 
Flower Fever 
Gum-Kino Diarrhea, dysentery, leucorrhoea, passive 
haemorrhages 
 
 
3.9. Clinical studies and plausible medicinal applications 
Although studies have been carried out on various biological activities of P. 
marsupium extracts and some of the isolated compounds in several animal models, a 
few reports are available on clinical studies with the extracts or the compounds and 
their medicinal applications (Anon, Wealth of India, 2003). Pterocarpus marsupium 
(PMS, Leguminnaceae family), commonly known as Bija, that has been 
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recommended as early as 1000 BC, by Sushruta for the treatment of diabetes. Various 
reports indicate the hypoglycemic activity of PMS both in experimental and clinical 
studies (Pandey & Sharma 1976; Remsberg et al., 2008; Manlio et al., 2005). 
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4. Aim and objective of the study 
Since pre-historic days attempts are being made to find out suitable drugs from 
natural sources for treatment of different diseases. The rational approaches, 
experience of folk medicine provide a valuable approach in the search for the 
development of new and useful therapeutic agents. Gradually keeping in pace with the 
scientific interpretations of the drug actions, the causes of the diseases, and the 
development in the field of chemistry and technology, intensive efforts are being 
directed towards the design and synthesis of new drugs. 
More recently a study by the World Health Organization (WHO) has shown that 
about 80% of the World‟s population still relies on traditional medicine.  This is of 
interest to a natural product chemist for many reasons. There is the possibility that the 
herb used in the traditional medicine is harmful to the patient, in which case the 
treatment may do more harm the good. Conversely, there is the possibility that the 
herbs used are not effective at all. That may not be of concern for minor ailments, but 
in more serious cases an ineffective treatment could result in the death of the patient. 
Hopefully, however, the herbs used are effective. If that is the case then investigation 
of that remedy could be of benefit to the remaining 20% of the World‟s population.  
Natural products still play a very important role in the medicine of the remaining 20% 
of the world‟s population. Between 1983 and 1994, 41% of new approved drugs have 
natural products as their source. This percentage becomes even higher when one 
examines anti-infective and anticancer compounds. For both classes, the percentage of 
drugs with natural products as their source increases to over 60%. 
Because natural products are most important in the areas of anti-infective, 
antioxidants and anticancer agents, some of the important contributions to these drug 
classes are worth closer inspection. In particular the anticancer drugs will be 
examined as that is the area of our research.  
 
Cancer is a multifactorial, multifaceted and multimechanistic disease requiring a 
multidimensional approach for its treatment, control and prevention. Cancer involves 
fundamental biological processes concerning disorganised cell replication, cell death 
and disorganization of organ structure. The annual estimates of cancer for the year 
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2001 in India is 0.98 million and the annual mortality in 2000 is 0.7 million. The 
incidence of cancer is on the rise, with multiple risk factors that involve interplay 
between genetic and environmental components.  
The aim of the research is to find out new anticancer drugs from indigenous plants 
which are potent and nontoxic agents. These plants are traditional medicinal plants. 
Their chemical characterization, mode of action and toxicity studies are yet to be 
established. Present project deals with phytochemical and pharmacological evaluation 
of of ethanol extract of Pterocarpus marsupium Roxb. bark with special reference to 
in-vitro antioxidant studies (DPPH, ABTS, Nitric oxide and hydrogen peroxide) and 
in vitro cytotoxicity (MTTS) studies. Normally herbal products are free from side 
effects/adverse effect and they are low cost medicines, which will be beneficial for the 
people of this country. Keeping this in view, we have selected two plants from the 
Kolli hills, Namakkal District of Tamil Nadu which are used by the tribes for the 
treatment of different types of diseases. The main objective of this work is to develop 
potent anticancer agent having no minimum side effects from indigenous plants for 
the therapeutic management. 
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5. Plan of work 
Phase I: 
5.1. Phytochemical studies 
 Collection and authentication of plants. 
 Extraction of plant material by using various solvent systems. 
 Preliminary phytochemical study for the identification of plant secondary 
constituents. 
Phase II: 
5.2. Pharmacological studies 
 Evaluation of anticancer activity of ethanol extract of Pterocarpus marsupium 
ROXB. bark (EEPM) against Ehrlich Ascites Carcinoma (EAC) bearing Swiss 
albino mice. 
 Evaluation of antioxidant enzymes and its parameters with special reference to 
cancer cell lines. 
Phase III: 
5.3. Statistical analysis 
 The data‟s were presented as mean ± SEM and were subjected to statistical 
analysis by Dunnett‟s test followed by one way ANOVA. P-value less than 
0.05 were considered statistically significant. 
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6. MATERIALS AND METHODS 
6.1. Phytochemical Studies 
Collection and Authentication of the Plant  
The bark of P. marsupium were collected in the month of October 2015, from Kolli 
Hills, Namakkal district of Tamil Nadu state, India.  The collected plants were 
authenticated by the Dr. G. Murthy, Botanical survey of India, Coimbatore, Tamil 
Nadu and the voucher specimen has been preserved in our laboratory for future 
reference (BSI/SC/5/PG/15-16/OCT). 
6.1.1 Extraction of Pterocarpus marsupium bark 
The barks of the tree were dried under shade with occasional shifting and made into 
coarse powder with a mechanical grinder. The powder material were first passed 
through sieve No.40 and then defatted with petroleum ether. The defatted powder 
materials thus obtained were further extracted by methanol for 72 hours in a Soxhlet 
extraction apparatus.  The solvent was removed under reduced pressure and a 
semisolid mass was vacuum dried so yields a solid residue. After complete drying, the 
extract material was weighed and the extractive value in percentage was calculated 
with reference to the air dried sample. Thus an ethanol extract of Pterocarpus 
marsupium bark (EEPM) was obtained. 
6.1.2. Preliminary phytochemical studies on ethanol extract of EEPM bark 
The ethanol extracts were subjected to qualitative tests for the detection of various 
plant constituents like carbohydrates, glycosides, proteins and amino acids, fixed oils 
and fats, gums and mucilages, alkaloids, phytosterols, flavanoids, tannins and 
phenolic compounds, saponins, triterpinoids etc.   
6.2 Pharmacological Studies 
6.2.1. In-Vivo anticancer activity of Pterocarpus marsupium bark 
Evaluation of anticancer activity of Pterocarpus marsupium against Ehrlich Ascites 
Carcinoma (EAC) bearing Swiss albino mice (Dacie & Lewis 1958; Wintrobe, 1961; 
D'Armour et al., 1965; Mazumder et al., 1997; Khanam et al., 1997; Gupta et al., 
2000; Kakali et al., 2001; Ray et al., 2002; Rajkapoor et al., 2004; Gupta et al., 2004a; 
Gupta et al., 2004b; Sivakumar et al., 2005; Ojha et al., 2006; Ohkawa et al., 1979).
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The present chapter deals with ethanol extract of Pterocarpus marsupium bark were 
evaluated for anticancer activity against Ehrlich Ascites Carcinoma (EAC) cells 
bearing Swiss albino mice.  
6.2.1a Preparation of extract drug and mode of administration                        
For the present anticancer study we used two concentration of ethanol extract of 
Pterocarpus marsupium in the dose of 100mg/kg and 200 mg/kg. It was prepared in 
suspension form by dissolving the methanol extract of required quantity in sterile 
physiological saline containing 1% carboxyl methyl cellulose (CMC). This aqueous 
suspension of EEPM were administered intraperitonially in the dose of 100mg/kg and 
200mg/kg throughout the experiment 
6.2.1b Chemical and reagent  
Vincristin (Oncocristin AQ, Sun Pharmaceutical India Ltd., Mumbai), Tryphan blue 
(Otta Kemi for Microscopy, Mumbai). 1-Chloro-2,4-dinitrobenzene (CDNB), Bovine 
serum albumin (Sigma chemical, St. Louis, MO, USA), Thiobarbituric acid, Nitro 
blue tetrazolium chloride (NBT) (Loba Chemie, Bombay, India), 5, 5'-dithiobis-(2-
nitrobenzoic acid) (DTNB) (Sisco research laboratory, Bombay, India). Reduced 
glutathione, Ascorbic acid, 2,4- dinitrophenylhydrazine, ferric chloride (DNPH), 2,2-
dipyridyl-p-phenylenediamine hydrochloride were obtained from S.D. Fine 
Chemicals, Mumbai, India. All the chemicals used in the present study are of 
analytical grade. 
6.2.1c Animals  
Studies were carried out by using adult Swiss albino mice weighing 20 + 2 gm.  They 
were obtained from Perundurai Medical College, Perundurai, Tamilnadu. The mice 
were grouped and housed in polypropylene cage containing paddy husk (procured 
locally) as bedding throughout the experiment and maintained under standard 
laboratory condition (Temp 25 + 2
o
C) and light (14 and 10 hr of light and dark, 
respectively).  The animals had free access to the food and water the mice were 
acclimatized to laboratory condition for 10 days before commencement of the 
experiment. The study was approved by the Institutional Animal Ethical Committee 
of J.K.K. Nattraja College of Pharmacy, Komarapalayam. 
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6.2.1d Cancer cell line  
EAC cells were obtained from Amala Cancer Research Center, Thrissur, Kerala, 
India. They were maintained by weekly intraperitoneal inoculation of 2 x10
6
 cells / 
mouse 
6.2.1e Treatment schedule  
 
The Swiss albino mice were divided into 14 groups of each 10 animals (n=10) and 
given food and water ad libitum. All the groups were injected with EAC (10
6
 
cells/mice) intraperitoneally except normal groups.  This was taken as day 0. On the 
first day, normal saline (0.9 % w/v, NaCl 5 ml/kg/day/mice) was administered to 
group-1. EAC control mice received only vehicle (propylene glycol 5 
ml/kg/day/mice: group-2).  The ethanol extracts of Pterocarpus marsupium, at the 
dose of 100 and 200 mg/kg/day/mice, were subsequently administered to animals in 
groups 3 and 4, respectively. Vincristine (0.8 mg/kg/mice), used as standard drug was 
injected to group 6, for 14 days intraperitoneally.  On 15
th
 day, after the last dose and 
18hr fasting five mice from each group were sacrificed for the study of anti-tumor 
activity, haematological parameter, and antioxidant enzymes estimation and rest of 
the animal of each group were kept to check the mean survival time (MST) and 
increase in the lifespan (%ILS) of the tumor scaring mice. 
6.2.1f Tumor growth response 
Anticancer effect of EEPM were assessed by observation of change with respect to 
body weight, ascetics tumor volume, packed cell volume, viable and non-viable tumor 
cell count, Mean survival time (MST) and percentage increase in life span  (% ILS). 
6.2.1g Tumor cell volume and packed cell volume 
The mice were dissected for collecting ascetic fluid from peritoneal cavity.  The 
transplantable tumor was carefully collected with the help of 5 ml sterile syringe and 
measured the tumor volume and the ascetic fluid was with draw in a graduated glass 
centrifuge tube and packed cell volume was determined by centrifuging at 1,000 g for 
5 min. 
6.2.1h Viable and non-viable cell count 
For viable and non-viable cell counting the ascetic cell were stained by the tryphan 
blue (0.4 % in normal saline), dye exclusion test and count was determined in a 
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Neubauer counting chamber.  The cells that did not take up the dye were viable and 
those that took the stain were non-viable. 
6.2.1i Mean survival and Percentage increased in life span  
The effect of EEPM on tumor growth was observed by MST and % ILS. MST of each 
group containing 5 mice were monitored by recording the mortality daily for 6 weeks 
and % ILS was calculated by using following equation. 
MST= (Day of first death + day of last death)/2. 
 
% LLS =         Mean survival time of treated group 
                       Mean survival time of control group 
6.3. Haematological Studies  
For the total count of red blood cells and white blood cells, the blood was drawn in to 
RBC and WBC pipette respectively, then diluted and counted in a Neubauer counting 
chamber (Wintrob et al., 1961). The Hemoglobin concentration was determined by 
using Sahli‟s hemoglobin meter (D‟Amour et al., 1965).  Deferential count of 
Leukocytes was done on freshly drawn blood film using Leishman‟s stain. The RBC, 
WBC, Hb %, and differential count were estimated from the normal, EAC (control) 
standard and EEPM-treated groups (Wintrobe et al., 1961). 
6.4. Biochemical Assay 
 
After the collection of blood samples, the mice were sacrificed and their liver was 
excised, rinsed in ice cold normal saline followed by cold 0.15 M Tris-Hcl (pH 7.4), 
blotted dry and weighed. A 10% w/v homogenate was prepared in 0.15 M Tris-Hcl 
buffer and a portion was utilized for the estimation of lipid peroxidation and a second 
portion of the same after precipitating proteins with TCA was used for the estimation 
of glutathione. The rest of the homogenate was centrifuged at 1500 rpm for 15 
minutes at 4
0
C. The supernatant thus obtained was used for the estimation of 
superoxide dismutase, catalase and protein (D‟Amour et al., 1965).   
6.4a Estimation of Superoxide dismutase (SOD)  
SOD activity of the brain tissue was analyzed using the method described by Kakkar 
et al. (1984). Assay mixture contained 0.1 ml of sample, 1.2 ml of sodium 
pyrophosphate buffer (pH 8.3, 0.052 M), 0.1 ml phenazine methosulphate (186 M), 
 x 100      
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0.3 ml of 300 M nitroblue tetrazolium, 0.2 ml NADH (750 M). Reaction was 
started by addition of NADH. After incubation at 30
0
 C for 90 s, the reaction was 
stopped by the addition of 0.1 ml glacial acetic acid. Reaction mixture was stirred 
vigorously with 4.0 ml of n-butanol. Mixture was allowed to stand for 10 minute, 
centrifuged and butanol layer was separated. Color intensity of the chromogen in the 
butanol layer was measured at 560 nm spectrophotometrically (LKB, Ultrospec II) 
and specfic activity of SOD was expressed as units/mg protein. 
6.4b Estimation of Catalase (CAT)  
Catalase activity was measured by the method of Aebi (1974). 0.1 ml of supernatant 
was added to cuvette containing 1.9 ml of 50 mM phosphate buffer (pH 77.0). 
Reaction was started by the addition of 1.0 ml of freshly prepared 30 mM H2O2. The 
rate of decomposition of H2O2 was measured spectrophotometrically from changes in 
absorbance at 240 nm. Activity of catalase was expressed as units/mg protein.  
6.4c Lipid peroxidation (LPO) 
 
The tissues were then homogenized in 0.1M buffer (pH 7.4) with a Teflon-glass 
homogenizer. Lipid peroxidation in this homogenate was determined by measuring 
the amounts of malondialdehyde (MDA) produced primarily, according to the method 
of Ohkawa et al. (1979). To 0.2 ml of tissue homogenate, 0.2 ml of 8.1% Sodium 
dodecyl sulphate (SDS), 1.5 ml of 20% acetic acid and 1.5 ml of 8% TBA were 
added. The volume of the mixture was made upto 4 ml with distilled water and then 
heated at 95
0 
C on a water bath for 60 minute using glass balls as condenser. After 
incubation the tubes were cooled to room temperature and final volume was made to 5 
ml in each tube. 5.0 ml of butanol:pyridine (15:1) mixture was added and the contents 
were vortexed thoroughly for 2 minute. After centrifugation at 3000 rpm for 10 min, 
the upper organic layer was taken and its OD read at 532 nm against an appropriate 
blank without the sample. The levels of lipid peroxides were expressed as n moles of 
thiobarbituric acid reactive substances (TBARS)/mg protein using an extinction 
coefficient of 1.56 x 10
5
M
-1
cm
–1
 (Dacie & Lewis 1958). 
6.4d Estimation of reduced glutathione (GSH)  
To measure the reduced glutathione (GSH) level, the tissue homogenate (in 0.1 M 
phosphate buffer pH 7.4) was taken. The procedure was followed initially as 
described by Ellman 1959. The homogenate was added with equal volume of 20% 
tetrachloroacetic acid containing 1 mM EDTA to precipitate the tissue proteins. The 
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mixture was allowed to stand for 5 minute prior to centrifugation for 10 minute at 
2000 rpm. The supernatant (200µl) was then transferred to a new set of test tubes and 
added 1.8 ml of the Ellman's reagent (5,5'-dithio bis-2-nitrobenzoic acid) (0.1mM) 
was prepared in 0.3M phosphate buffer with 1% of sodium citrate solution). Then all 
the test tubes make upto the volume of 2ml. After completion of the total reaction, 
solutions were measured at 412 nm against blank. Absorbance values were compared 
with a standard curve generated from standard curve from known GSH (Ohkawa et 
al., 1979). 
6.4e Estimation of protein content  
The prepared 10% w/v liver homogenate in phosphate buffer  solution (pH 7.4) was 
used for the estimation of protein content by using Alen, H., (1995) method.  The 
prepared homogenate were centrifuged at 1500 g for 15 min at 4
o
C.  The Absorbance 
and Transmittance were measured in spectrophotometer at 540 nm.  The protein 
content was calculated (Lowry et al., 1951). The amount of protein was expressed in 
gm of protein in 100 ml. 
6.5. Statistical Analysis 
The experimental results were expressed as the mean ± S.E.M. Data were assessed by 
the method of analysis of ANOVA, followed by Dunnet‟s t-test; p value of < 0.05 was 
considered as statistically significant. 
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7. RESULTS 
7.1. Phytochemical studies 
7.1.1. Extraction and preliminary phytochemical studies on ethanol extracts of P. 
marsupium bark (EEPM) 
The dried powder materials of barks of P. marsupium were extracted with methanol in 
a Soxhlet apparatus. The yield was 7.06 % w/w. The tested ethanol extracts of P. 
marsupium showed the presence of phytoconstituents such as carbohydrates, sterols, 
glycosides, phytosterols and steroids, proteins & amino acids, flavonoids and 
triterpenoids. The results are shown in table no.4 and 5. 
Table No.3 Data showing the extractive value of ethanol extract of Pterocarpus 
marsupium 
 
Plant Name 
Parts 
used 
Method used 
 
Solvent Used %w/w yield 
Using 
Pterocarpus 
marsupium 
bark 
Continuous hot 
percolation process 
Ethanol                
(95 % v/v) 
7.06 
 
Table No. 4 Data showing the preliminary phytochemical screening of the 
methanol extracts of the Pterocarpus marsupium 
Sl. 
No 
Phytoconstituents P. marsupium 
1. Carbohydrates + 
2. Glycosides + 
3. Alkaloids - 
4. 
Phytosterol  and 
steroids 
+ 
5. Flavonoids + 
6. 
Proteins&Amino 
Acids. 
+ 
7. Tannins - 
8. Resins - 
9. Gums and mucilages - 
10. Triterpenoids + 
+ Present; -Absent 
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7.2. Pharmacological studies 
7.2.1.In-vivo anticancer activity of ethanol extracts of Pterocarpus marsupium bark 
against Ehrlich Ascites Carcinoma (EAC) bearing Swiss albino mice.  
The investigations on the ethanol extracts of Pterocarpus marsupium (EEPM) bark 
revealed significant anticancer activity in EAC bearing mice.  The effects of EEPM at 
the dose of 100 mg/kg and 200 mg/kg on various parameters are presented below: 
7.2.1a Effect of mean survival time and tumour growth 
The effect of EEPM at the dose of 100 mg/kg and 200 mg/kg on the mean survival 
time and % increase in life span of EAC bearing mice is shown in table no.19. In the 
EAC control group, the mean survival time was 22.21+0.25 days and it increased to 
26.32+1.20, 24.26+0.33 (100 mg/kg) and 30.65+0.66, (200 mg/kg) days following 
EEPM treatment. The mean survival time in the standard drug group (vincristine 0.8 
mg/kg), was found to be 31.25+40.90 days. 
Treatment with EEPM at the doses of 100 and 200 mg/kg significantly (p<0.01) 
reduced the tumor volume, packed cell volume, and viable cell count in a dose 
dependent manner as compared to that of  EAC control groups.  Furthermore, 
nonviable tumor cell counts at different doses of EEPM were increased when 
compared with the EAC control group us shown in table no.18. 
Table No.5 Effect of EEPM on survival time on EAC bearing mice. 
S. 
No. 
Experimental  groups 
Mean survival time 
(MST) days 
% increase in 
life span 
1 
Normal control (normal saline 
5 ml/kg b.w.) 
- - 
2 EAC control 19.15±1.52 - 
3 EAC + EEPM (100 mg /kg) 26.32±1.20 7.58 
4 EAC + EEPM (200 mg /kg) 30.65±1.66 15.85 
5 
EAC + Vincristine (0.8 mg / kg)   
(standard) 
31.25±2.38 31.74 
All the values are expressed as mean ±SEM, n =8 in each group. Values are 
significantly different from standard (Vincristine). *P < 0.05; **P < 0.01; ***P < 
0.001. 
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Fig No.1. Effect of EEPM on survival time on EAC bearing mice. 
 
Table No.6 Effect of EEPM on tumour volume, packed cell volume, viable and 
non-viable tumour cell count of EAC bearing mice 
Parameters 
EAC 
control 
EEPM  
100 mg/kg 
EEPM  
200 mg/kg 
Standard 
vincristine   
0.8 mg/kg 
Body weight (gm) 27.18±0.15 24.52±0.85* 23.12±0.65* 24.18±0.56* 
Tumour volume (ml) 6.28±0.04 4.56±0.15* 3.69±0.14** 3.41±0.18*** 
Packed cell volume 
(ml) 
2.51±0.10 1.68±0.08* 0.96±0.07** 1.27±0.11* 
Viable tumour cell 
count (x 10
7
 cells 
/ml) 
12.26±0.09 8.54±0.08** 5.21±0.05*** 5.09±0.05*** 
Non-viable tumour 
cell count (x 10
7
 
cells / ml) 
0.57±0.07 0.69±0.05* 1.19±0.05* 1.29±0.09* 
All the values are expressed as mean ±SEM, n =8 in each group. Values are 
significantly different from standard (Vincristine). *P < 0.05; **P < 0.01; ***P < 
0.001. 
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Figure No.2. Effect of EEPM on tumour volume, packed cell volume, viable and 
non-viable tumour cell count of EAC bearing mice 
 
7.2.2. Effect on haematological parameters  
The findings are shown in table no.21, wherein the hemoglobin content in EAC 
control mice (9.80 g%) were significantly decreased when compared with normal 
mice. The hemoglobin content in EAC-treated mice increased (100 mg/kg: 10.55 and 
200: mg/kg 11.67 g%) in EEPM-treated groups. Moderate changes in the RBC counts 
were observed in the EEPM-treated mice. The total WBC counts were significantly 
increased in EAC bearing mice as compared to normal mice; whereas, EEPM 
treatment, at the dose of 100 and 200 mg/kg, significantly reduced the WBC count as 
compared to control.  
In differential leukocyte count, the % of lymphocyte decreased while the % of 
neutrophiles increased in EAC control; in EEPM-treated mice, the % changes in the 
lymphocyte levels were found to be increased while the % changes in the neutrophiles 
were found to be decreased significantly, as compared with EAC control. 
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Table No.7. Effect of EEPM on haematological parameters of EAC bearing mice 
 
 
 
 
 
 
 
 
 
 
 
Parameter 
Normal 
saline 0.5 
ml/kg 
EAC control 
2 X 10
6
 cells / 
mice 
EAC + 
EEPM 100 
mg/kg 
EAC + 
EEPM 200 
mg/kg 
EAC 
Cell + 
Vincrist
ine  0.8 
mg/kg 
Haemoglo
bin (gm) 
12.58±0.52 9.57±0.15 10.08±0.15 11.56±0.18 
11.970.0
5* 
Total RBC 
million/m
m
3
 
6.84±0.28 3.85±0.051 4.95±0.15 5.68±0.17 
5.89±0.0
59 
Total 
WBC 
(thousand/
mm
3
) 
7.54±0.054 2.59±0.06* 15.65±0.04 12.58±0.02 
9.54±0.0
57 
Lympocyte
s % 
79.57±0.25 35.65±0.87* 50.25±0.89 64.65±0.47 
61.52±0.
41 
Neutrophil
s % 
1.81±0.03 0.88±0.025 1.08±0.07 1.42±0.36 
1.61±0.0
21 
Monocytes 
% 
31.54±0.25 54.23±0.17* 46.16±0.07 41.32±0.04 
39.56±0.
52 
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Figure No.3. Effect of EEPM on haemoglobin in EAC bearing mice. 
 
Figure No.4. Effect of EEPM on total RBC in EAC bearing mice 
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Figure No.5. Effect of EEPM on total WBC in EAC bearing mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
18
T
o
ta
l 
W
B
C
 i
n
 m
il
li
o
n
s/
cu
m
m
 
Normal saline 0.5 ml/kg
EAC control 2 X 106 cells / mice
EAC + EEPM 100 mg/kg
EAC + EEPM 200 mg/kg
EAC Cell + Vincristine  0.8 mg/kg
 44 
 
Figure No.6. Effect of EEPM on differential WBC in EAC bearing mice. 
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7.2.3. Effect of EEPM on biochemical  parameters  
The findings are shown in table no. 8. The results on the studies on the biochemical 
paramenters indicated that the perturbations in the levels of antioxicdant enzyme 
levels were normalized by EEPM in a dose dependent manner.  
Table No.8. Effect of EEPM on on different biochemical parameters in EAC 
bearing mice. 
Parameter 
Normal 
saline 0.5 
ml/kg 
EAC 
control 2 X 
10
6
 cells / 
mice 
EAC + 
EEPM 100 
mg/kg 
EAC + 
EEPM 200 
mg / kg 
LPO (n moles 
MDA/gm of 
tissue) 
0.81±0.02 1.24±0.09* 1.02±0.20 0.92±0.01 
CAT      
(units /mg  
tissues) 
2.78±0.72 1.61±0.15* 1.96±1.20 2.15±0.04 
GSH mg/gm 
of tissue 
2.42±0.03 1.62±0.12 1.89±0.30 2.12±0.23 
SOD 
units/mg of 
protein 
4.43±0.43 3.23±0.22 3.47±0.24 3.92±0.22 
Protein 
content 
(gm/100 ml) 
14.56±0.69* 19.54±0.76 18.74±0.96 18.36±0.16 
 
All the values are expressed as mean ± SEM, n =5. EAC control group compared with 
normal. Experimental group, compared with EAC control. Values are significantly 
different from compared groups. ANOVA, *P < 0.05; **P < 0.01; ***P < 0.001. 
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Figure No.7. Effect of EEPM on on different biochemical parameters in EAC 
bearing mice 
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Figure No.8. Effect of EEPM on on protein content in EAC bearing mice 
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8. DISCUSSION 
The present study was carried out to evaluate the anticancer effect of EEPM in EAC 
bearing mice. The EEPM-treated mice, at the dose of 100 and 200 mg/kg, 
significantly increased the survival time, inhibited the tumor volume, packed cell 
volume, tumor cell count and brought back the hematological parameter to more or 
less normal levels. The extract also restored the hepatic lipid peroxidation and 
antioxidant enzymes such as a glutathione content, SOD, and catalase (CAT) in tumor 
bearing mice to near normal level. 
In EAC bearing mice, a rapid increase in ascites tumor volume was noted. Ascites 
fluid is the direct nutritional source for tumor cells and a rapid increase in ascetic fluid 
with tumor growth would be a means to meet the nutritional requirement of tumor 
cells
105
.  
Treatment with EEPM inhibited the tumor volume, tumor cell count, and increased 
the percentage of tryphan blue positive stained dead cells in tumor bearing mice.  The 
reliable criteria for judging the value of any anticancer drug are the prolongation of 
the life span of animals.
106
 The EEPM treatment decreased the ascetic fluid volume, 
viable cell count and increased the percentage of life span. It may be concluded that 
EEPM may act by decreasing the nutritional fluid volume and arresting the tumor 
growth, increases the life span of EAC bearing mice.  
Usually in cancer chemotherapy the major problems that are being encountered are 
myelosuppression and anemia.
107,108
 The anemia encountered in tumor bearing mice is 
mainly due to reduction in RBC or hemoglobin percentage, and this may occur either 
due to iron deficiency or due to hemolytic or myclopathic conditions
109
. Treatment 
with EEPM restored the hemoglobin content, RBC and WBC count more or less to 
normal levels. This indicates that EEPM may possess protective action on the 
hematopoietic system. 
Lipid peroxidation, an autocatalytic free radical chain propagating reaction, is known 
to be associated with pathological condition of cell. Malondialdehyde (MDA), the end 
product of lipid peroxidation, was reported to be higher in cancer tissue than in non-
cancerous organ
109
.  A major target of reactive oxygen species (ROS) is cell 
membrane, due to the high content of polyunsaturated fatty acid. ROS mediated lipid 
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peroxidation causes damage to cellular DNA, membrane structure and inhibition of 
functions of several enzymes and alteration in the immune system. In cancer, 
enormous production of free radicals in the system has been reported.  A close 
relationship between free radical activity and neoplastic transformation has been 
shown.  Antioxidants play a vital role in scavenging reactive oxygen species and 
protect the cells from oxidative damage. In EAC bearing mice the level of lipid 
peroxidation was significantly increased. Administration of EEPM at the dose level of 
200 mg/kg animal groups significantly inhibited as the elevated level of lipid 
peroxidation as compared with control animals. 
Glutathione (GSH), a potent inhibitor of neoplastic process plays an important role in 
endogenous antioxidant system that is found particularly in high concentration in liver 
and it is known to have key function in protective process. Excessive production of  
free radicals resulted in oxidative stress, which leads to damage of macro molecules 
for example, lipid peroxidation in vivo.
110 
It was also reported that the presence of 
tumors in the human body or in experimental animals is known to affect many 
functions of the vital organs, especially in the liver, even when the site of the tumor 
does not interfere directly with organ function .
111
 The present study indicated 
depletion in GSH contents in the EAC control group, which was found to be 
significantly increased following treatment with EEPM in comparison to control 
groups and this may be attributed to the antioxidant and free radical mechanism.  
The functions of the SOD and CAT activities, present in all oxygen metabolizing 
cells, is to provide a defence against the potentially damaging reactivity of superoxide 
and hydrogen peroxide. Inhibitions in the activities of SOD and CAT as a result of 
tumor growth were also reported
112
. Similar findings were observed in the present 
investigation with EAC bearing mice. The administration of EEPM at the doses 100 
and 200 mg/kg significantly altered status of SOD and CAT levels in a dose 
dependent manner as compared with control. 
Cells are also equipped with enzymatic antioxidant mechanisms that play an 
important role in the elimination of free radicals. SOD, CAT and glutathione 
peroxides are involved in the clearance of superoxide and hydrogen peroxide (H2O2) 
radicals. SOD catalyses the diminution of superoxide into H2O2, which has to be 
eliminated by glutathione peroxidase and or catalase
113
. In correlation, it has been 
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reported  that a decrease in SOD activity in  EAC bearing mice which might be due to 
loss of Mn
2+
 containing SOD activity in EAC cells and the loss of mitochondria, 
leading to a decrease in total SOD activity in the liver.
114 
A small amount of catalase 
in tumor cell was reported.
115
 The inhibition of SOD and CAT activities as a result of 
tumor growth was also reported.
114
 Similar findings were observed in the present 
investigation with EAC bearing mice.  
The administration of EEPM at different doses significantly increased the SOD and 
CAT levels as compared to that of DAL control group. 
It was reported that plant derived extracts containing antioxidant principles showed 
cytotoxicity towards tumor cells
116
 and anticancer activity in experimental animals.
117 
  
  
Anticancer activity of these antioxidants is either through induction of apoptosis
118
 or 
by inhibition of neovascularization.
119 
The implication of free radicals in tumors is 
well documented.
120, 121 
The free radical hypothesis supported the fact that the 
antioxidant and anticancer principles present in the extract. 
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